Membership

TFS

TFS Trial Form Support International is a full-service clinical, FDA-inspected CRO with headquarters in Lund, Sweden. Since 1996, TFS has provided the life science industry with a wide range of clinical contract services. The focus is on three business areas: Early Clinical Development, Project Delivery and Contract Placement Solutions. TFS has extensive experience in six main core therapeutic areas. Over 470 highly competent employees are working in 16 countries across Europe, USA, Japan and India. In the beacon classification scheme TFS Trial Form Support International AB meets the criteria for Register Data. The international network of monitored patient populations kept by TFS Trial Form Support International constitutes register data. TFS Trial Form Support International AB has research experience in; oncology, cardilogy, endocrinology, CNS, microbiology, immunology, gastrointestinal, phychiatric, repiratory, and nephrology. The size and international experience of TFS Trial Form Support International AB meets the criteria for Clinical Trials.

Zellaco

At Zellaco, we are passionate about developing smart, reliable, and innovative solutions in electronics design and embedded systems software. Founded in 2021 and backed by many years of collective industry experience, we are today an established company that combines fresh thinking and flexibility with the expertise required to deliver innovative and robust solutions.

Whether it is within medtech or electronics, our expertise lies in control and measurement systems, IoT, and connected devices. We help companies bring their ideas to life—from concept to finished product—working on both brand-new development projects and the optimization of existing systems. As a development partner, we offer cutting-edge technical expertise and close collaboration throughout the entire process.

MedTech Bridge

MedTech Bridge: Successful and efficient trans-Atlantic commercialization for ambitious EU medtech companies

MedTech Bridge is your go-to-market partner for US commercialization and expansion . We help ambitious European medtech companies navigate the complexities of entering, commercializing and scaling in the US through a highly relational, network-driven approach.

MedTech Bridge is a network-based platform providing members with ongoing access to a growing network of 300+ senior advisors and 800+ medtech and startup colleagues across the US . Rather than providing snapshot consulting, we aim to follow and support our member companies over the long term, giving them access to the right expertise, relationships and opportunities as their needs evolve.

MedTech Bridge provides access to webinars and direct interactions with US experts, US delegations, participation in US medtech events, and virtual and face-to-face meetings with relevant industry, commercial, research and investment contacts — and much more.

Through the network, members can connect with experienced professionals and industry leaders across the full medtech commercialization journey, including US go-to-market, reimbursement, regulatory affairs, clinical adoption, market access, manufacturing, supply chain, distribution, financing and strategic partnerships .

Our experts engage directly with companies, take the time to understand their technology, business model and ambitions, and help address critical questions such as:

• Where does your solution fit within the US healthcare system?
• Who are your early adopters, customers and strategic partners?
• What clinical behaviour needs to change to drive adoption?
• Who are your key competitors and how should you differentiate?
• What reimbursement and market-access pathway should you pursue?
• What regulatory and clinical requirements need to be addressed?
• How should you establish your US manufacturing, supply chain and commercial setup?
• Which investors, research institutions, industry partners and other stakeholders should you engage?

The value is in the relationship over time. Members can access different experts and resources as their company progresses from market assessment and regulatory preparation to first customers, commercial scaling and broader US expansion.

”And there is no fixed endpoint. Sometimes a mentor becomes an advisor, board member or fractional CxO  and that is exactly the kind of long-term relationship we aim to create.”

INGA Health project / Aalto University Finland

Transforming labor induction from subjective procedure into precise, personalized and data-drive care

Harmac Medical Products

Harmac is Changing the Lives of Patients, Employees and the Communities in Which We Work.

From contract manufacturing new to enhancing next-generation products, Harmac supports all stages of the product life cycle.

We are here to support you in any technical challenge you might encounter, from product feasibility and initial tooling design, through volume manufacturing and assembly, to final packaging and sterilization.

Anabiotec

From analytical data to drug development insight
Anabiotec is your independent partner for CMC analytics and (pre-)clinical bioanalysis. Leveraging 25+ years of experience and proactive project management, we accelerate your development timelines and safeguard your milestones.

Evotec International

Evotec is a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we accelerate the journey from concept to cure — faster, smarter, and with greater precision. Our expertise spans small molecules, biologics, cell therapies and associated modalities, supported by proprietary platforms such as Molecular Patient Databases, PanOmics and iPSC-based disease modeling. With flexible partnering models tailored to our customers’ needs, we work with all Top 20 Pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. Our offerings range from standalone services to fully integrated R&D programs and long-term strategic partnerships, combining scientific excellence with operational agility. Through Just – Evotec Biologics, we redefine biologics development and manufacturing to improve accessibility and affordability. With a strong portfolio of over 100 proprietary R&D assets, most of them being co-owned, we focus on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology. Evotec’s global team of around 4,500 experts operates from sites in Europe and the U.S., offering complementary technologies and services as synergistic centers of excellence.

Follow on LinkedIn and X/Twitter @Evotec

IHE  The Swedish Institute for Health Economics

The Swedish Institute for Health Economics, IHE, is a well-established, independent health economic research institute that provides high-quality research and expert consultation in the field of health care. We have ongoing projects with over 50 customers worldwide representing national authorities, pharmaceutical companies, healthcare providers, industry associations, and patient groups.

IHE was founded in 1979 as the first health economic research center in Sweden and is one of the oldest health economic research centers in Europe.

In addition to the head office in Lund, IHE also has an office in central Stockholm.

IHE is home to over 30 highly qualified, multidisciplinary specialists in health economics, medical sciences and statistics. This makes IHE one of Sweden’s largest teams of health economists. IHE has close collaborations with academia, and several employees also work part-time at Lund University or Karolinska Institutet.

SGS Clinical Research

SGS Pharma Clinical Research is a leading CRO specializing in early-stage development and functional biometrics (Phases I–IV). With a strong presence in Europe and the Americas, SGS offers a comprehensive range of clinical trial services, including full early-phase drug development consultancy, clinical project management and monitoring, biometrics, as well as medical safety and regulatory services. SGS operates its own clinical pharmacology unit in Belgium featuring a viral challenge testing facility and a phase I patient unit based in Hungary. SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a strong therapeutic focus on Infectious Diseases, Vaccines, Respiratory, Dermatology and Oncology.

Precision for Medicine

Enriching the latest science, technology and data to conquer the complexity of developing novel therapies.

We’ve all known patients facing critical illnesses. Your work may one day provide hope to those patients. Bringing that day forward is why Precision for Medicine exists. We are the first global, precision medicine clinical research organization. We incorporate laboratory expertise, clinical trial excellence, and data intelligence to deliver critical insights into patient biology.